Evidence map›Paper›PMID 18347230›Full record

ArticleHypertension (Dallas, Tex. : 1979)2008

Modulation of reflex function by endogenous angiotensins in older transgenic rats with low glial angiotensinogen.

Amy C Arnold, Atsushi Sakima, Detlev Ganten, Carlos M Ferrario, Debra I Diz

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Endogenous leptin contributes to baroreflex suppression within the solitary tract nucleus of aged rats.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  8. Article
  9. Brain renin-angiotensin system in the nexus of hypertension and aging.Hypertension research : official journal of the Japanese Society of Hypertension · 2013
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Autonomic control of the heart is altered in Sprague-Dawley rats with spontaneous hydronephrosis.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  18. Angiotensin peptides and central autonomic regulation.Current opinion in pharmacology · 2011
    Review
  19. Animal aging and regulation of sympathetic nerve discharge.Journal of applied physiology (Bethesda, Md. : 1985) · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amy C ArnoldHypertension and Vascular Research Center and Physiology and Pharmacology Department, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1032, USA.
Atsushi Sakima
Detlev Ganten
Carlos M Ferrario
Debra I Diz
University of the Ryukyus · JP

Funding

Vaso-Hormonal Mechanisms in HypertensionP01HL051952 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GROBAN, LEANNE · 1994 to 2019
$34.8M
NHLBI NIH HHS HL-51952NHLBI NIH HHS P01 HL051952
6 · The paper itself

Abstract

Age-related impairments in baroreflex sensitivity in Sprague-Dawley rats are associated with low solitary tract nucleus content of angiotensin-(1-7). However, transgenic rats with low-brain angiotensinogen resulting from glial overexpression of an antisense oligonucleotide to angiotensinogen (ASrAOGEN) are spared age-related declines in cardiovascular function characteristic of Sprague-Dawley rats. We examine whether cardiovascular and reflex actions of angiotensin-(1-7) persist in the solitary tract nucleus of older (16 to 22 months) ASrAOGEN rats. Baroreflex sensitivity for control of heart rate and chemosensitive vagal afferent activation in response to phenylbiguanide were measured before and after bilateral microinjection of the angiotensin II type 1 receptor antagonist candesartan and angiotensin-(1-7) receptor antagonist (D-Ala(7))-angiotensin-(1-7) in urethane/chloralose-anesthetized rats. In older anesthetized ASrAOGEN rats, candesartan had no effect, whereas (D-Ala(7))-angiotensin-(1-7) significantly reduced baroreflex sensitivity (1.80+/-0.43 versus 0.50+/-0.17 ms/mm Hg). Phenylbiguanide responses were attenuated by injection of candesartan (-79+/-6 versus -55+/-12 mm Hg and -277+/-12 versus -156+/-27 bpm; P<0.05). In addition, resting blood pressure was reduced by injection of candesartan or (D-Ala(7))-angiotensin-(1-7). Within the solitary tract nucleus of older ASrAOGEN rats, it appears that glial angiotensinogen is the main source of angiotensin II attenuation of baroreflex sensitivity; endogenous angiotensin-(1-7) from nonglial sources enhances baroreflex sensitivity; nonglial sources of angiotensin II contribute to chemosensitive vagal afferent activation; and receptors for both peptides modulate resting arterial pressure under anesthesia. These results suggest a novel mechanism for the preservation of baroreflex sensitivity during aging.

Indexed as

AgingAngiotensin IAngiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensinogenAngiotensinsAnimalsAnimals, Genetically ModifiedBaroreflexBenzimidazolesBiphenyl CompoundsBlood PressureHeart RateMaleNeurogliaPeptide FragmentsAngiotensin Iangiotensin I (1-7)Angiotensin IIAngiotensin II Type 1 Receptor BlockersAngiotensinogenAngiotensinsBenzimidazolesBiphenyl CompoundscandesartanPeptide FragmentsTetrazoles

Identifiers

PMID18347230
PMCPMC2483961
OpenAlexW2161067713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.